Prognosis and rescue therapy for sepsis-related severe thrombocytopenia in critically ill patients

This study aims to explore the effect of severe thrombocytopenia on the prognosis of sepsis and the impact of a platelet-elevating drug (recombinant human thrombopoietin, rhTPO) for these sepsis patients. In this study, we included 249 sepsis patients diagnosed by sepsis 3.0, and these patients were classified into the three groups based on PC: normal (PC>= 100 x 109/L), mild-moderate thrombocytopenia (50 x 109/L
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news